Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-23-000123

Chief Executive Officer sold 10,178 shares at $25.48 ($259,335)

  • Chief Executive Officer acquired 22,691 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Goff Brian · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-08-08 Exercise or conversion : show line 1 in the form 10b5-1 +22,691 36,770 D
2023-08-08 Sale : show line 2 in the form 10b5-1 −10,178 $25.48 $259,335 26,592 D
Open-market sales · 10,178 sh · avg $25.48 · $259,335

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-08-08 Exercise or conversion : show line 3 in the form 10b5-1 Restricted stock units −22,691 45,382 D
Loading xslF345X05/wk-form4_1691698025.xml…